ICCM Stock Analysis: Buy, Sell, or Hold?
ICCM - IceCure Medical Ltd. Ordinary Shares
$2.21
-0.18 (-7.54%)
▼
5d:
-39.29%
30d:
+816.97%
90d:
+202.73%
WAIT
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jun 03, 2026
0d
Get Alerted When ICCM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ICCM is down 39.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ICCM is down 39.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ICCM is currently trading at $2.21, which is considered slightly high relative to its 30-day fair value range of $-0.37 to $2.59. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.6) compared to its historical average (7.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ICCM is in a downtrend. Immediate support is located at $0.12, while resistance sits at $5.69. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: ICCM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $44.50 (+1761.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICCM is in a downtrend. Immediate support is located at $0.12, while resistance sits at $5.69. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: ICCM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $44.50 (+1761.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$-0.37 -
$2.59
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 1761.9% below Wall St target ($44.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -39.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$-0.37 -
$2.59
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$5.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.57
Wall Street Target
$44.50
(+1761.9%)
Revenue Growth (YoY)
25.7%
PE vs Historical
-0.6 vs 7.5
CHEAP
Share & Embed Analysis
Last updated: June 15, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 53 HOLD |
